Heparin-binding epidermal growth factor-like growth factor | |
---|---|
Trade Name | |
Orphan Indication | Necrotizing enterocolitis |
USA Market Approval | USA |
USA Designation Date | 2006-09-18 00:00:00 |
Sponsor | Trillium Therapeutics, Inc.;96 Skyway Avenue, M9W 4Y4; |